Mefloquine and malaria prophylaxis

Drug and Therapeutics Bulletin

Volumn 36, Issue 3, 1998, Pages 20-22

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DOXYCYCLINE; MEFLOQUINE; PROGUANIL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; META ANALYSIS; MOOD; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; SLEEP DISORDER; VERTIGO;

EID: 0031922125     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1998.36320     Document Type: Article

References (16)

1. Mefloquine - a new antimalanal. DTB 1991; 29: 51-2.
2. Mefloquine, Data sheet, UK. Roche Products Limited, May 1997.
3. Bradley DJ, Warhurst DC. Guidelines for the prevention of malaria in travellers from the united Kingdom. Commun Dis Rep CDR Rev 1997; 7: R137-52.
4. Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ. Risk of malaria in British residents returning from malarious areas. BMJ 1990; 300: 499-503.
5. Steffen R, Fuchs E, Schildknecht J et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341: 1299-303.
6. R 6. Ohrt C, Richie TL, Widjaja H et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997; 126: 963-72.
7. Lobel HO, Bernard KW, Williams SL, Hightower AW, Patchen LC, Campbell CC. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine (need for a better dosing regimen). JAMA 1991; 265: 361-4.
8. ter Kuile FO, Kosten F, Luxemburger C et al. Mefloquine treatment of acute ralciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organ 1995; 73: 631-42.
9. Phillips-Howard PA, ter Kuile FO. CNS adverse events associated with antimalarial agents. Fact or action? Drug Saf 1995; 12: 370-83.
10. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996; 313: 525-8.
11. Huzly D, Schönfeld C, Beuerle W, Bienzle U. Malaria chemoprophylaxis in German tourists: a propsective study on compliance and adverse reactions. J Travel Med 1995; 3: 148-55.
12. R 12. Boudreau E, Schuster B, Sanchez J et al. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 1993; 44: 257-65.
13. R 13. Croft AMJ, Clayton TC, World MJ. Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial. Trans R Soc Trop Med Hyg 1997; 91: 199-203.
14. R 14. Davis TME, Dembo LG, Kaye-Eddie SA, Hewitt BJ, Hislop RG, Batty KT, Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebocontrolled trial. Br J Clin Pharmacol 1996; 42: 415-21.
15. M 15. Croft A, Garner P. Mefloquine to prevent malaria: a systematic review of trials. BMJ 1997; 315: 1412-6.
16. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341: 848-51.